Author: Satyam, Abhigyan; Tsokos, Maria G.; Brook, Olga R.; Hecht, Jonathan L.; Moulton, Vaishali R.; Tsokos, George C.
Title: Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19 Cord-id: zdyk6bsi Document date: 2021_3_24
ID: zdyk6bsi
Snippet: Lung inflammation and damage is prominent in people infected with SARS-Cov-2 and a major determinant of morbidity and mortality. We report the deposition of complement components in the lungs of people who succumbed to COVID-19 consistent with the activation of the classical and the alternative pathways. Our study provides strong rationale for the expansion of trials involving the use of complement inhibitors to treat patients with COVID-19.
Document: Lung inflammation and damage is prominent in people infected with SARS-Cov-2 and a major determinant of morbidity and mortality. We report the deposition of complement components in the lungs of people who succumbed to COVID-19 consistent with the activation of the classical and the alternative pathways. Our study provides strong rationale for the expansion of trials involving the use of complement inhibitors to treat patients with COVID-19.
Search related documents:
Co phrase search for related documents- accountability health insurance portability act and lung tissue: 1
- accountability health insurance portability and acute respiratory syndrome: 1
- accountability health insurance portability and lung tissue: 1
- activation involved and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- activation involved and lung inflammation: 1, 2, 3, 4
- activation involved and lung injury: 1, 2, 3, 4, 5, 6, 7
- activation involved and lung tissue: 1
- activation mechanism and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- activation mechanism and lung inflammation: 1
- activation mechanism and lung injury: 1, 2, 3, 4, 5, 6, 7
- activation mechanism and lung tissue: 1
- activation pathway and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66
- activation pathway and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- activation pathway and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- activation pathway and lung injury aggravate: 1, 2
- activation pathway and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute alveolar hemorrhage and lung inflammation: 1
- acute alveolar hemorrhage and lung injury: 1
- acute alveolar hemorrhage and lung tissue: 1
Co phrase search for related documents, hyperlinks ordered by date